menu toggle

Cell and gene therapy: Creating connections amid complexity


Product developments in cell and gene therapy are both among the most groundbreaking and the most complex. Cell and gene therapy product launch success hinges on investment in the right technology and data solutions, and that also means finding the right partner.

In speaking with Fierce Pharma, Doug Cook, president of commercialization services and animal health, explained his role in manufacturer offerings, from the clinical trials stage to consulting through patient support and payer strategy. Hear more from Cook in his interview with Fierce Pharma.

Cell and gene therapy solutions

When healthcare advances, so must the processes to connect patients to the therapies they need. And because a rapidly changing cell and gene therapy industry requires an equally innovative partner, AmerisourceBergen is committed to delivering solutions that enable this connection.

Let’s build the future together.